Abstract
Amyotrophic lateral sclerosis (ALS) is a disease caused by the degeneration of motor neurons (MNs) leading to progressive muscle weakness and atrophy. Several molecular pathways have been implicated, such as glutamate-mediated excitotoxicity, defects in cytoskeletal dynamics and axonal transport, disruption of RNA metabolism, and impairments in proteostasis. ALS is associated with protein accumulation in the cytoplasm of cells undergoing neurodegeneration, which is a hallmark of the disease. In this review, we focus on mechanisms of proteostasis, particularly protein degradation, and discuss how they are related to the genetics of ALS. Indeed, the genetic bases of the disease with the implication of more than 30 genes associated with familial ALS to date, together with the important increase in understanding of endoplasmic reticulum (ER) stress, proteasomal degradation, and autophagy, allow researchers to better understand the mechanisms underlying the selective death of motor neurons in ALS. It is clear that defects in proteostasis are involved in this type of cellular degeneration, but whether or not these mechanisms are primary causes or merely consequential remains to be clearly demonstrated. Novel cellular and animal models allowing chronic expression of mutant proteins, for example, are required. Further studies linking genetic discoveries in ALS to mechanisms of protein clearance will certainly be crucial in order to accelerate translational and clinical research towards new therapeutic targets and strategies.
Similar content being viewed by others
Abbreviations
- MN:
-
Motor neuron
- ALS:
-
Amyotrophic lateral sclerosis
- UPS:
-
Ubiquitin proteasome system
- ERAD:
-
Endoplasmic reticulum-associated protein degradation
- CAP:
-
Chaperone-assisted proteasomal degradation
- CMA:
-
Chaperone-mediated autophagy
- CASA:
-
Chaperone-assisted selective autophagy
- Ub:
-
Ubiquitin
- SUMO:
-
Small ubiquitin-like modifier
- SG:
-
Stress granules
- C9ORF72:
-
Chromosome 9 open reading frame 72
- SOD1:
-
Superoxide dismutase 1
- TARDBP:
-
TAR DNA-binding protein
- FUS:
-
Fused in sarcoma
- OPTN:
-
Optineurin
- SQSTM1:
-
p62/sequestosome1
- VCP:
-
Valosin-containing protein
- UBQNL2:
-
Ubiquilin 2
- VAPB:
-
Vesicle-associated membrane protein-associated protein B/C
- TBK1:
-
TANK-binding kinase 1
- FIG4:
-
FIG4 phosphoinositide 5-phosphatase
- SIGMAR1:
-
Sigma non-opioid intracellular receptor 1
- CCNF:
-
Cyclin F
- PDIA:
-
Protein disulfide isomerase family A member
References
Marin B, Boumédiene F, Logroscino G et al (2016) Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis. Int J Epidemiol. https://doi.org/10.1093/ije/dyw061
Taylor JP, Brown RH, Cleveland DW (2016) Decoding ALS: from genes to mechanism. Nature 539:197–206. https://doi.org/10.1038/nature20413
Brown RH, Al-Chalabi A (2017) Amyotrophic lateral sclerosis. N Engl J Med 377:162–172. https://doi.org/10.1056/NEJMra1603471
Forman MS, Trojanowski JQ, Lee VM-Y (2004) Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs. Nat Med 10:1055–1063. https://doi.org/10.1038/nm1113
Oda M, Akagawa N, Tabuchi Y, Tanabe H (1978) A sporadic juvenile case of the amyotrophic lateral sclerosis with neuronal intracytoplasmic inclusions. Acta Neuropathol (Berl) 44:211–216
Murayama S, Ookawa Y, Mori H et al (1989) Immunocytochemical and ultrastructural study of Lewy body-like hyaline inclusions in familial amyotrophic lateral sclerosis. Acta Neuropathol (Berl) 78:143–152
Matsumoto S, Hirano A, Goto S (1990) Ubiquitin-immunoreactive filamentous inclusions in anterior horn cells of Guamanian and non-Guamanian amyotrophic lateral sclerosis. Acta Neuropathol (Berl) 80:233–238
Blokhuis AM, Groen EJN, Koppers M et al (2013) Protein aggregation in amyotrophic lateral sclerosis. Acta Neuropathol (Berl) 125:777–794. https://doi.org/10.1007/s00401-013-1125-6
Neumann M, Sampathu DM, Kwong LK et al (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314:130–133. https://doi.org/10.1126/science.1134108
Mackenzie IRA, Bigio EH, Ince PG et al (2007) Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann Neurol 61:427–434. https://doi.org/10.1002/ana.21147
Tan C-F, Eguchi H, Tagawa A et al (2007) TDP-43 immunoreactivity in neuronal inclusions in familial amyotrophic lateral sclerosis with or without SOD1 gene mutation. Acta Neuropathol (Berl) 113:535–542. https://doi.org/10.1007/s00401-007-0206-9
Kabashi E, Valdmanis PN, Dion P et al (2008) TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet 40:572–574. https://doi.org/10.1038/ng.132
Sreedharan J, Blair IP, Tripathi VB et al (2008) TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319:1668–1672. https://doi.org/10.1126/science.1154584
Kedersha N, Stoecklin G, Ayodele M et al (2005) Stress granules and processing bodies are dynamically linked sites of mRNP remodeling. J Cell Biol 169:871–884. https://doi.org/10.1083/jcb.200502088
Hara T, Nakamura K, Matsui M et al (2006) Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 441:885–889. https://doi.org/10.1038/nature04724
Mizushima N (2010) The role of the Atg1/ULK1 complex in autophagy regulation. Curr Opin Cell Biol 22:132–139. https://doi.org/10.1016/j.ceb.2009.12.004
Amick J, Roczniak-Ferguson A, Ferguson SM (2016) C9orf72 binds SMCR8, localizes to lysosomes, and regulates mTORC1 signaling. Mol Biol Cell 27:3040–3051. https://doi.org/10.1091/mbc.E16-01-0003
Sullivan PM, Zhou X, Robins AM et al (2016) The ALS/FTLD associated protein C9orf72 associates with SMCR8 and WDR41 to regulate the autophagy-lysosome pathway. Acta Neuropathol Commun 4:51. https://doi.org/10.1186/s40478-016-0324-5
Schröder B, Wrocklage C, Pan C et al (2007) Integral and associated lysosomal membrane proteins. Traffic Cph Den 8:1676–1686. https://doi.org/10.1111/j.1600-0854.2007.00643.x
Lee DY, Brown EJ (2012) Ubiquilins in the crosstalk among proteolytic pathways. Biol Chem 393:441–447. https://doi.org/10.1515/hsz-2012-0120
Williams KL, Warraich ST, Yang S et al (2012) UBQLN2/ubiquilin 2 mutation and pathology in familial amyotrophic lateral sclerosis. Neurobiol Aging 33:2527.e3–2527.e10. https://doi.org/10.1016/j.neurobiolaging.2012.05.008
Buchan JR, Kolaitis R-M, Taylor JP, Parker R (2013) Eukaryotic stress granules are cleared by autophagy and Cdc48/VCP function. Cell 153:1461–1474. https://doi.org/10.1016/j.cell.2013.05.037
Vance C, Rogelj B, Hortobágyi T et al (2009) Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323:1208–1211. https://doi.org/10.1126/science.1165942
Neumann M, Rademakers R, Roeber S et al (2009) A new subtype of frontotemporal lobar degeneration with FUS pathology. Brain J Neurol 132:2922–2931. https://doi.org/10.1093/brain/awp214
Fecto F, Yan J, Vemula S et al (2011) SQstm1 mutations in familial and sporadic amyotrophic lateral sclerosis. Arch Neurol 68:1440–1446. https://doi.org/10.1001/archneurol.2011.250
Rosen DR, Siddique T, Patterson D et al (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362:59–62. https://doi.org/10.1038/362059a0
Al-Chalabi A, van den Berg LH, Veldink J (2017) Gene discovery in amyotrophic lateral sclerosis: implications for clinical management. Nat Rev Neurol 13:96–104. https://doi.org/10.1038/nrneurol.2016.182
Iida A, Hosono N, Sano M, et al. (2012) Novel deletion mutations of OPTN in amyotrophic lateral sclerosis in Japanese. Neurobiol Aging 33:1843.e19-24. doi: https://doi.org/10.1016/j.neurobiolaging.2011.12.037
Tashiro Y, Urushitani M, Inoue H et al (2012) Motor neuron-specific disruption of proteasomes, but not autophagy, replicates amyotrophic lateral sclerosis. J Biol Chem 287:42984–42994. https://doi.org/10.1074/jbc.M112.417600
Xia D, Tang WK, Ye Y (2016) Structure and function of the AAA+ ATPase p97/Cdc48p. Gene 583:64–77. https://doi.org/10.1016/j.gene.2016.02.042
Oakes JA, Davies MC, Collins MO (2017) TBK1: a new player in ALS linking autophagy and neuroinflammation. Mol Brain 10:5. https://doi.org/10.1186/s13041-017-0287-x
Nishimura AL, Mitne-Neto M, Silva HCA et al (2004) A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Am J Hum Genet 75:822–831. https://doi.org/10.1086/425287
Ciechanover A, Heller H, Elias S et al (1980) ATP-dependent conjugation of reticulocyte proteins with the polypeptide required for protein degradation. Proc Natl Acad Sci U S A 77:1365–1368
Komander D (2009) The emerging complexity of protein ubiquitination. Biochem Soc Trans 37:937–953. https://doi.org/10.1042/BST0370937
Michelle C, Vourc’h P, Mignon L, Andres CR (2009) What was the set of ubiquitin and ubiquitin-like conjugating enzymes in the eukaryote common ancestor? J Mol Evol 68:616–628. https://doi.org/10.1007/s00239-009-9225-6
Li W, Bengtson MH, Ulbrich A et al (2008) Genome-wide and functional annotation of human E3 ubiquitin ligases identifies MULAN, a mitochondrial E3 that regulates the organelle’s dynamics and signaling. PLoS One. https://doi.org/10.1371/journal.pone.0001487
Natarajan C, Takeda K (2017) Regulation of various DNA repair pathways by E3 ubiquitin ligases. J Cancer Res Ther 13:157–169. https://doi.org/10.4103/0973-1482.204879
Cheroni C, Peviani M, Cascio P et al (2005) Accumulation of human SOD1 and ubiquitinated deposits in the spinal cord of SOD1G93A mice during motor neuron disease progression correlates with a decrease of proteasome. Neurobiol Dis 18:509–522. https://doi.org/10.1016/j.nbd.2004.12.007
Puttaparthi K, Wojcik C, Rajendran B et al (2003) Aggregate formation in the spinal cord of mutant SOD1 transgenic mice is reversible and mediated by proteasomes. J Neurochem 87:851–860
Urushitani M, Kurisu J, Tateno M et al (2004) CHIP promotes proteasomal degradation of familial ALS-linked mutant SOD1 by ubiquitinating Hsp/Hsc70. J Neurochem 90:231–244. https://doi.org/10.1111/j.1471-4159.2004.02486.x
Urushitani M, Kurisu J, Tsukita K, Takahashi R (2002) Proteasomal inhibition by misfolded mutant superoxide dismutase 1 induces selective motor neuron death in familial amyotrophic lateral sclerosis. J Neurochem 83:1030–1042
Leigh PN, Whitwell H, Garofalo O et al (1991) Ubiquitin-immunoreactive intraneuronal inclusions in amyotrophic lateral sclerosis. Morphology, distribution, and specificity. Brain J Neurol 114(Pt 2):775–788
Migheli A, Autilio-Gambetti L, Gambetti P et al (1990) Ubiquitinated filamentous inclusions in spinal cord of patients with motor neuron disease. Neurosci Lett 114:5–10
Hyun D-H, Lee M, Halliwell B, Jenner P (2003) Proteasomal inhibition causes the formation of protein aggregates containing a wide range of proteins, including nitrated proteins. J Neurochem 86:363–373
Kabashi E, Agar JN, Taylor DM et al (2004) Focal dysfunction of the proteasome: a pathogenic factor in a mouse model of amyotrophic lateral sclerosis. J Neurochem 89:1325–1335. https://doi.org/10.1111/j.1471-4159.2004.02453.x
Cheroni C, Marino M, Tortarolo M et al (2009) Functional alterations of the ubiquitin-proteasome system in motor neurons of a mouse model of familial amyotrophic lateral sclerosis. Hum Mol Genet 18:82–96. https://doi.org/10.1093/hmg/ddn319
Tsuji S, Kikuchi S, Shinpo K et al (2005) Proteasome inhibition induces selective motor neuron death in organotypic slice cultures. J Neurosci Res 82:443–451. https://doi.org/10.1002/jnr.20665
Deng H-X, Chen W, Hong S-T et al (2011) Mutations in UBQLN2 cause dominant X-linked juvenile and adult-ons et al. S and ALS/dementia. Nature 477:211–215. https://doi.org/10.1038/nature10353
Johnson JO, Mandrioli J, Benatar M et al (2010) Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron 68:857–864. https://doi.org/10.1016/j.neuron.2010.11.036
Gallagher PS, Clowes Candadai SV, Gardner RG (2014) The requirement for Cdc48/p97 in nuclear protein quality control degradation depends on the substrate and correlates with substrate insolubility. J Cell Sci 127:1980–1991. https://doi.org/10.1242/jcs.141838
Christianson JC, Ye Y (2014) Cleaning up in the endoplasmic reticulum: ubiquitin in charge. Nat Struct Mol Biol 21:325–335. https://doi.org/10.1038/nsmb.2793
Stolz A, Wolf DH (2010) Endoplasmic reticulum associated protein degradation: a chaperone assisted journey to hell. Biochim Biophys Acta 1803:694–705. https://doi.org/10.1016/j.bbamcr.2010.02.005
Oyanagi K, Yamazaki M, Takahashi H et al (2008) Spinal anterior horn cells in sporadic amyotrophic lateral sclerosis show ribosomal detachment from, and cisternal distention of the rough endoplasmic reticulum. Neuropathol Appl Neurobiol 34:650–658. https://doi.org/10.1111/j.1365-2990.2008.00941.x
Lautenschlaeger J, Prell T, Grosskreutz J (2012) Endoplasmic reticulum stress and the ER mitochondrial calcium cycle in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Off Publ World Fed Neurol Res Group Mot Neuron Dis 13:166–177. https://doi.org/10.3109/17482968.2011.641569
Rozas P, Bargsted L, Martínez F et al (2017) The ER proteostasis network in ALS: determining the differential motoneuron vulnerability. Neurosci Lett 636:9–15. https://doi.org/10.1016/j.neulet.2016.04.066
Grosskreutz J, Van Den Bosch L, Keller BU (2010) Calcium dysregulation in amyotrophic lateral sclerosis. Cell Calcium 47:165–174. https://doi.org/10.1016/j.ceca.2009.12.002
Soo KY, Halloran M, Sundaramoorthy V et al (2015) Rab1-dependent ER-Golgi transport dysfunction is a common pathogenic mechanism in SOD1, TDP-43 and FUS-associated ALS. Acta Neuropathol (Berl) 130:679–697. https://doi.org/10.1007/s00401-015-1468-2
Liebelt F, Vertegaal ACO (2016) Ubiquitin-dependent and independent roles of SUMO in proteostasis. Am J Physiol Cell Physiol 311:C284–C296. https://doi.org/10.1152/ajpcell.00091.2016
Schimmel J, Larsen KM, Matic I et al (2008) The ubiquitin-proteasome system is a key component of the SUMO-2/3 cycle. Mol Cell Proteomics MCP 7:2107–2122. https://doi.org/10.1074/mcp.M800025-MCP200
Fei E, Jia N, Yan M et al (2006) SUMO-1 modification increases human SOD1 stability and aggregation. Biochem Biophys Res Commun 347:406–412. https://doi.org/10.1016/j.bbrc.2006.06.092
Niikura T, Kita Y, Abe Y (2014) SUMO3 modification accelerates the aggregation of ALS-linked SOD1 mutants. PLoS One 9:e101080. https://doi.org/10.1371/journal.pone.0101080
Dangoumau A, Marouillat S, Burlaud Gaillard J et al (2015) Inhibition of pathogenic mutant SOD1 aggregation in cultured motor neuronal cells by prevention of its SUMOylation on lysine 75. Neurodegener Dis. https://doi.org/10.1159/000439254
Dangoumau A, Veyrat-Durebex C, Blasco H et al (2013) Protein SUMOylation, an emerging pathway in amyotrophic lateral sclerosis. Int J Neurosci 123:366–374. https://doi.org/10.3109/00207454.2012.761984
Oh S-M, Liu Z, Okada M et al (2010) Ebp1 sumoylation, regulated by TLS/FUS E3 ligase, is required for its anti-proliferative activity. Oncogene 29:1017–1030. https://doi.org/10.1038/onc.2009.411
Arndt V, Rogon C, Höhfeld J (2007) To be, or not to be--molecular chaperones in protein degradation. Cell Mol Life Sci CMLS 64:2525–2541. https://doi.org/10.1007/s00018-007-7188-6
Matsumoto G, Stojanovic A, Holmberg CI et al (2005) Structural properties and neuronal toxicity of amyotrophic lateral sclerosis-associated Cu/Zn superoxide dismutase 1 aggregates. J Cell Biol 171:75–85. https://doi.org/10.1083/jcb.200504050
Komatsu M, Waguri S, Chiba T et al (2006) Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 441:880–884. https://doi.org/10.1038/nature04723
Rea SL, Majcher V, Searle MS, Layfield R (2014) SQSTM1 mutations—bridging Paget disease of bone and ALS/FTLD. Exp Cell Res 325:27–37. https://doi.org/10.1016/j.yexcr.2014.01.020
Webster CP, Smith EF, Bauer CS et al (2016) The C9orf72 protein interacts with Rab1a and the ULK1 complex to regulate initiation of autophagy. EMBO J 35:1656–1676. https://doi.org/10.15252/embj.201694401
Gal J, Ström A-L, Kwinter DM et al (2009) Sequestosome 1/p62 links familial ALS mutant SOD1 to LC3 via an ubiquitin-independent mechanism. J Neurochem 111:1062–1073. https://doi.org/10.1111/j.1471-4159.2009.06388.x
Wild P, Farhan H, McEwan DG et al (2011) Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth. Science 333:228–233. https://doi.org/10.1126/science.1205405
Freischmidt A, Wieland T, Richter B et al (2015) Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia. Nat Neurosci 18:631–636. https://doi.org/10.1038/nn.4000
Ji CH, Kwon YT (2017) Crosstalk and interplay between the ubiquitin-proteasome system and autophagy. Mol Cells 40:441–449. https://doi.org/10.14348/molcells.2017.0115
Selimovic D, Porzig BBOW, El-Khattouti A et al (2013) Bortezomib/proteasome inhibitor triggers both apoptosis and autophagy-dependent pathways in melanoma cells. Cell Signal 25:308–318. https://doi.org/10.1016/j.cellsig.2012.10.004
Matsumoto G, Wada K, Okuno M et al (2011) Serine 403 phosphorylation of p62/SQSTM1 regulates selective autophagic clearance of ubiquitinated proteins. Mol Cell 44:279–289. https://doi.org/10.1016/j.molcel.2011.07.039
Ferreira JV, Soares AR, Ramalho JS et al (2015) K63 linked ubiquitin chain formation is a signal for HIF1A degradation by chaperone-mediated autophagy. Sci Rep 5:10210. https://doi.org/10.1038/srep10210
Renton AE, Majounie E, Waite A et al (2011) A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72:257–268. https://doi.org/10.1016/j.neuron.2011.09.010
DeJesus-Hernandez M, Mackenzie IR, Boeve BF et al (2011) Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72:245–256. https://doi.org/10.1016/j.neuron.2011.09.011
Majounie E, Renton AE, Mok K et al (2012) Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol 11:323–330. https://doi.org/10.1016/S1474-4422(12)70043-1
Liu Y, Pattamatta A, Zu T et al (2016) C9orf72 BAC mouse model with motor deficits and neurodegenerative features of ALS/FTD. Neuron 90:521–534. https://doi.org/10.1016/j.neuron.2016.04.005
Schipper LJ, Raaphorst J, Aronica E et al (2016) Prevalence of brain and spinal cord inclusions, including dipeptide repeat proteins, in patients with the C9ORF72 hexanucleotide repeat expansion: a systematic neuropathological review. Neuropathol Appl Neurobiol 42:547–560. https://doi.org/10.1111/nan.12284
Koppers M, Blokhuis AM, Westeneng H-J et al (2015) C9orf72 ablation in mice does not cause motor neuron degeneration or motor deficits. Ann Neurol 78:426–438. https://doi.org/10.1002/ana.24453
Chaineau M, Ioannou MS, McPherson PS (2013) Rab35: GEFs, GAPs and effectors. Traffic Cph Den 14:1109–1117. https://doi.org/10.1111/tra.12096
Amick J, Ferguson SM (2017) C9orf72: at the intersection of lysosome cell biology and neurodegenerative disease. Traffic Cph Den. https://doi.org/10.1111/tra.12477
Zu T, Liu Y, Bañez-Coronel M et al (2013) RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia. Proc Natl Acad Sci U S A 110:E4968–E4977. https://doi.org/10.1073/pnas.1315438110
Mori K, Arzberger T, Grässer FA et al (2013) Bidirectional transcripts of the expanded C9orf72 hexanucleotide repeat are translated into aggregating dipeptide repeat proteins. Acta Neuropathol (Berl) 126:881–893. https://doi.org/10.1007/s00401-013-1189-3
Türk M, Haaker G, Winter L et al (2014) C9ORF72-ALS: P62- and ubiquitin-aggregation pathology in skeletal muscle. Muscle Nerve 50:454–455. https://doi.org/10.1002/mus.24283
Serpente M, Fenoglio C, Cioffi SMG et al (2015) Profiling of ubiquitination pathway genes in peripheral cells from patients with frontotemporal dementia due to C9ORF72 and GRN mutations. Int J Mol Sci 16:1385–1394. https://doi.org/10.3390/ijms16011385
Gupta R, Lan M, Mojsilovic-Petrovic J et al (2017) The proline/arginine dipeptide from hexanucleotide repeat expanded C9ORF72 inhibits the proteasome. eNeuro. https://doi.org/10.1523/ENEURO.0249-16.2017
Gomez-Deza J, Lee Y-B, Troakes C et al (2015) Dipeptide repeat protein inclusions are rare in the spinal cord and almost absent from motor neurons in C9ORF72 mutant amyotrophic lateral sclerosis and are unlikely to cause their degeneration. Acta Neuropathol Commun 3:38. https://doi.org/10.1186/s40478-015-0218-y
Zhang Y-J, Jansen-West K, Xu Y-F et al (2014) Aggregation-prone c9FTD/ALS poly(GA) RAN-translated proteins cause neurotoxicity by inducing ER stress. Acta Neuropathol (Berl) 128:505–524. https://doi.org/10.1007/s00401-014-1336-5
Al-Sarraj S, King A, Troakes C et al (2011) p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS. Acta Neuropathol (Berl) 122:691–702. https://doi.org/10.1007/s00401-011-0911-2
O’Rourke JG, Bogdanik L, Yáñez A et al (2016) C9orf72 is required for proper macrophage and microglial function in mice. Science 351:1324–1329. https://doi.org/10.1126/science.aaf1064
Webster CP, Smith EF, Grierson AJ, De Vos KJ (2016) C9orf72 plays a central role in Rab GTPase-dependent regulation of autophagy. Small GTPases 1–10. https://doi.org/10.1080/21541248.2016.1240495
Radunovíc A, Leigh PN (1996) Cu/Zn superoxide dismutase gene mutations in amyotrophic lateral sclerosis: correlation between genotype and clinical features. J Neurol Neurosurg Psychiatry 61:565
Reaume AG, Elliott JL, Hoffman EK et al (1996) Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat Genet 13:43–47. https://doi.org/10.1038/ng0596-43
Tu PH, Raju P, Robinson KA et al (1996) Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions. Proc Natl Acad Sci U S A 93:3155–3160
Shibata N, Asayama K, Hirano A, Kobayashi M (1996) Immunohistochemical study on superoxide dismutases in spinal cords from autopsied patients with amyotrophic lateral sclerosis. Dev Neurosci 18:492–498
Bruijn LI, Becher MW, Lee MK et al (1997) ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 18:327–338
Dangoumau A, Verschueren A, Hammouche E et al (2014) Novel SOD1 mutation p.V31A identified with a slowly progressive form of amyotrophic lateral sclerosis. Neurobiol Aging 35:266.e1–266.e4. https://doi.org/10.1016/j.neurobiolaging.2013.07.012
Valentine JS, Hart PJ (2003) Misfolded CuZnSOD and amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A 100:3617–3622. https://doi.org/10.1073/pnas.0730423100
McAlary L, Aquilina JA, Yerbury JJ (2016) Susceptibility of mutant SOD1 to form a destabilized monomer predicts cellular aggregation and toxicity but not in vitro aggregation propensity. Front Neurosci 10:499. https://doi.org/10.3389/fnins.2016.00499
Nishitoh H, Kadowaki H, Nagai A et al (2008) ALS-linked mutant SOD1 induces ER stress- and ASK1-dependent motor neuron death by targeting Derlin-1. Genes Dev 22:1451–1464. https://doi.org/10.1101/gad.1640108
Hetz C, Mollereau B (2014) Disturbance of endoplasmic reticulum proteostasis in neurodegenerative diseases. Nat Rev Neurosci 15:233–249. https://doi.org/10.1038/nrn3689
Niwa J-I, Ishigaki S, Hishikawa N et al (2002) Dorfin ubiquitylates mutant SOD1 and prevents mutant SOD1-mediated neurotoxicity. J Biol Chem 277:36793–36798. https://doi.org/10.1074/jbc.M206559200
Sone J, Niwa J, Kawai K et al (2010) Dorfin ameliorates phenotypes in a transgenic mouse model of amyotrophic lateral sclerosis. J Neurosci Res 88:123–135. https://doi.org/10.1002/jnr.22175
Yung C, Sha D, Li L, Chin L-S (2016) Parkin protects against misfolded SOD1 toxicity by promoting its aggresome formation and autophagic clearance. Mol Neurobiol 53:6270–6287. https://doi.org/10.1007/s12035-015-9537-z
Stürner E, Behl C (2017) The role of the multifunctional BAG3 protein in cellular protein quality control and in disease. Front Mol Neurosci 10:177. https://doi.org/10.3389/fnmol.2017.00177
Chhangani D, Endo F, Amanullah A et al (2016) Mahogunin ring finger 1 confers cytoprotection against mutant SOD1 aggresomes and is defective in an ALS mouse model. Neurobiol Dis 86:16–28. https://doi.org/10.1016/j.nbd.2015.11.017
Hadano S, Mitsui S, Pan L et al (2016) Functional links between SQSTM1 and ALS2 in the pathogenesis of ALS: cumulative impact on the protection against mutant SOD1-mediated motor dysfunction in mice. Hum Mol Genet 25:3321–3340. https://doi.org/10.1093/hmg/ddw180
Daoud H, Valdmanis PN, Kabashi E et al (2009) Contribution of TARDBP mutations to sporadic amyotrophic lateral sclerosis. J Med Genet 46:112–114. https://doi.org/10.1136/jmg.2008.062463
Millecamps S, Salachas F, Cazeneuve C et al (2010) SOD1, ANG, VAPB, TARDBP, and FUS mutations in familial amyotrophic lateral sclerosis: genotype-phenotype correlations. J Med Genet 47:554–560. https://doi.org/10.1136/jmg.2010.077180
Scotter EL, Chen H-J, Shaw CE (2015) TDP-43 proteinopathy and ALS: insights into disease mechanisms and therapeutic targets. Neurother J Am Soc Exp Neurother 12:352–363. https://doi.org/10.1007/s13311-015-0338-x
Lin G, Mao D, Bellen HJ (2017) Amyotrophic lateral sclerosis pathogenesis converges on defects in protein homeostasis associated with TDP-43 mislocalization and proteasome-mediated degradation overload. Curr Top Dev Biol 121:111–171. https://doi.org/10.1016/bs.ctdb.2016.07.004
Farrawell NE, Lambert-Smith IA, Warraich ST et al (2015) Distinct partitioning of ALS associated TDP-43, FUS and SOD1 mutants into cellular inclusions. Sci Rep 5:13416. https://doi.org/10.1038/srep13416
Edbauer D, Haass C (2016) An amyloid-like cascade hypothesis for C9orf72 ALS/FTD. Curr Opin Neurobiol 36:99–106. https://doi.org/10.1016/j.conb.2015.10.009
Araki W, Minegishi S, Motoki K et al (2014) Disease-associated mutations of TDP-43 promote turnover of the protein through the proteasomal pathway. Mol Neurobiol 50:1049–1058. https://doi.org/10.1007/s12035-014-8644-6
Hans F, Fiesel FC, Strong JC et al (2014) UBE2E ubiquitin-conjugating enzymes and ubiquitin isopeptidase Y regulate TDP-43 protein ubiquitination. J Biol Chem 289:19164–19179. https://doi.org/10.1074/jbc.M114.561704
Lamark T, Johansen T (2010) Autophagy: links with the proteasome. Curr Opin Cell Biol 22:192–198. https://doi.org/10.1016/j.ceb.2009.11.002
Scotter EL, Vance C, Nishimura AL et al (2014) Differential roles of the ubiquitin proteasome system and autophagy in the clearance of soluble and aggregated TDP-43 species. J Cell Sci 127:1263–1278. https://doi.org/10.1242/jcs.140087
Bose JK, Huang C-C, Shen C-KJ (2011) Regulation of autophagy by neuropathological protein TDP-43. J Biol Chem 286:44441–44448. https://doi.org/10.1074/jbc.M111.237115
Barmada SJ, Serio A, Arjun A et al (2014) Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models. Nat Chem Biol 10:677–685. https://doi.org/10.1038/nchembio.1563
Monahan Z, Shewmaker F, Pandey UB (2016) Stress granules at the intersection of autophagy and ALS. Brain Res 1649:189–200. https://doi.org/10.1016/j.brainres.2016.05.022
Afroz T, Hock E-M, Ernst P et al (2017) Functional and dynamic polymerization of the ALS-linked protein TDP-43 antagonizes its pathologic aggregation. Nat Commun 8:45. https://doi.org/10.1038/s41467-017-00062-0
Kwiatkowski TJ, Bosco DA, Leclerc AL et al (2009) Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323:1205–1208. https://doi.org/10.1126/science.1166066
Deng H, Gao K, Jankovic J (2014) The role of FUS gene variants in neurodegenerative diseases. Nat Rev Neurol 10:337–348. https://doi.org/10.1038/nrneurol.2014.78
Kino Y, Washizu C, Kurosawa M et al (2015) FUS/TLS deficiency causes behavioral and pathological abnormalities distinct from amyotrophic lateral sclerosis. Acta Neuropathol Commun. https://doi.org/10.1186/s40478-015-0202-6
Shang Y, Huang EJ (2016) Mechanisms of FUS mutations in familial amyotrophic lateral sclerosis. Brain Res 1647:65–78. https://doi.org/10.1016/j.brainres.2016.03.036
Vance C, Scotter EL, Nishimura AL et al (2013) ALS mutant FUS disrupts nuclear localization and sequesters wild-type FUS within cytoplasmic stress granules. Hum Mol Genet 22:2676. https://doi.org/10.1093/hmg/ddt117
Daigle JG, Lanson NA, Smith RB et al (2013) RNA-binding ability of FUS regulates neurodegeneration, cytoplasmic mislocalization and incorporation into stress granules associated with FUS carrying ALS-linked mutations. Hum Mol Genet 22:1193–1205. https://doi.org/10.1093/hmg/dds526
Ito D, Suzuki N (2011) Conjoint pathologic cascades mediated by ALS/FTLD-U linked RNA-binding proteins TDP-43 and FUS. Neurology 77:1636–1643. https://doi.org/10.1212/WNL.0b013e3182343365
Sun Z, Diaz Z, Fang X et al (2011) Molecular determinants and genetic modifiers of aggregation and toxicity for the ALS disease protein FUS/TLS. PLoS Biol 9:e1000614. https://doi.org/10.1371/journal.pbio.1000614
Shiihashi G, Ito D, Yagi T et al (2016) Mislocated FUS is sufficient for gain-of-toxic-function amyotrophic lateral sclerosis phenotypes in mice. Brain J Neurol 139:2380–2394. https://doi.org/10.1093/brain/aww161
Ryu H-H, Jun M-H, Min K-J et al (2014) Autophagy regulates amyotrophic lateral sclerosis-linked fused in sarcoma-positive stress granules in neurons. Neurobiol Aging 35:2822–2831. https://doi.org/10.1016/j.neurobiolaging.2014.07.026
Soo KY, Sultana J, King AE et al (2015) ALS-associated mutant FUS inhibits macroautophagy which is restored by overexpression of Rab1. Cell Death Discov 1:15030. https://doi.org/10.1038/cddiscovery.2015.30
Rezaie T, Child A, Hitchings R et al (2002) Adult-onset primary open-angle glaucoma caused by mutations in optineurin. Science 295:1077–1079. https://doi.org/10.1126/science.1066901
Maruyama H, Morino H, Ito H et al (2010) Mutations of optineurin in amyotrophic lateral sclerosis. Nature 465:223–226. https://doi.org/10.1038/nature08971
Del Bo R, Tiloca C, Pensato V et al (2011) Novel optineurin mutations in patients with familial and sporadic amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 82:1239–1243. https://doi.org/10.1136/jnnp.2011.242313
Mao J, Xia Q, Liu C et al (2017) A critical role of Hrd1 in the regulation of optineurin degradation and aggresome formation. Hum Mol Genet. https://doi.org/10.1093/hmg/ddx096
Li F, Xie X, Wang Y et al (2016) Structural insights into the interaction and disease mechanism of neurodegenerative disease-associated optineurin and TBK1 proteins. Nat Commun 7:12708. https://doi.org/10.1038/ncomms12708
Tumbarello DA, Waxse BJ, Arden SD et al (2012) Autophagy receptors link myosin VI to autophagosomes to mediate Tom1-dependent autophagosome maturation and fusion with the lysosome. Nat Cell Biol 14:1024–1035. https://doi.org/10.1038/ncb2589
Ying H, Yue BYJT (2015) Optineurin: The autophagy connection. Exp Eye Res. https://doi.org/10.1016/j.exer.2015.06.029
Shen W-C, Li H-Y, Chen G-C et al (2015) Mutations in the ubiquitin-binding domain of OPTN/optineurin interfere with autophagy-mediated degradation of misfolded proteins by a dominant-negative mechanism. Autophagy 11:685–700. https://doi.org/10.4161/auto.36098
Sundaramoorthy V, Walker AK, Tan V et al (2015) Defects in optineurin- and myosin VI-mediated cellular trafficking in amyotrophic lateral sclerosis. Hum Mol Genet 24:3830–3846. https://doi.org/10.1093/hmg/ddv126
Markovinovic A, Cimbro R, Ljutic T et al (2017) Optineurin in amyotrophic lateral sclerosis: Multifunctional adaptor protein at the crossroads of different neuroprotective mechanisms. Prog Neurobiol 154:1–20. https://doi.org/10.1016/j.pneurobio.2017.04.005
Nakazawa S, Oikawa D, Ishii R et al (2016) Linear ubiquitination is involved in the pathogenesis of optineurin-associated amyotrophic lateral sclerosis. Nat Commun 7:12547. https://doi.org/10.1038/ncomms12547
Le Ber I, Camuzat A, Guerreiro R et al (2013) SQstm1 mutations in french patients with frontotemporal dementia or frontotemporal dementia with amyotrophic lateral sclerosis. JAMA Neurol 70:1403–1410. https://doi.org/10.1001/jamaneurol.2013.3849
Teyssou E, Takeda T, Lebon V et al (2013) Mutations in SQSTM1 encoding p62 in amyotrophic lateral sclerosis: genetics and neuropathology. Acta Neuropathol (Berl) 125:511–522. https://doi.org/10.1007/s00401-013-1090-0
Vadlamudi RK, Joung I, Strominger JL, Shin J (1996) p62, a phosphotyrosine-independent ligand of the SH2 domain of p56lck, belongs to a new class of ubiquitin-binding proteins. J Biol Chem 271:20235–20237. https://doi.org/10.1074/jbc.271.34.20235
Pankiv S, Clausen TH, Lamark T et al (2007) p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem 282:24131–24145. https://doi.org/10.1074/jbc.M702824200
Goode A, Butler K, Long J et al (2016) Defective recognition of LC3B by mutant SQSTM1/p62 implicates impairment of autophagy as a pathogenic mechanism in ALS-FTLD. Autophagy 12:1094–1104. https://doi.org/10.1080/15548627.2016.1170257
Lattante S, de Calbiac H, Le Ber I et al (2015) Sqstm1 knock-down causes a locomotor phenotype ameliorated by rapamycin in a zebrafish model of ALS/FTLD. Hum Mol Genet 24:1682–1690. https://doi.org/10.1093/hmg/ddu580
Harder B, Jiang T, Wu T et al (2015) Molecular mechanisms of Nrf2 regulation and how these influence chemical modulation for disease intervention. Biochem Soc Trans 43:680–686. https://doi.org/10.1042/BST20150020
Katsuragi Y, Ichimura Y, Komatsu M (2015) p62/SQSTM1 functions as a signaling hub and an autophagy adaptor. FEBS J 282:4672–4678. https://doi.org/10.1111/febs.13540
Pan J-A, Sun Y, Jiang Y-P et al (2016) TRIM21 ubiquitylates SQSTM1/p62 and suppresses protein sequestration to regulate redox homeostasis. Mol Cell 61:720–733. https://doi.org/10.1016/j.molcel.2016.02.007
Watts GDJ, Wymer J, Kovach MJ et al (2004) Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet 36:377–381. https://doi.org/10.1038/ng1332
Ishigaki S, Hishikawa N, Niwa J et al (2004) Physical and functional interaction between dorfin and valosin-containing protein that are colocalized in ubiquitylated inclusions in neurodegenerative disorders. J Biol Chem 279:51376–51385. https://doi.org/10.1074/jbc.M406683200
Müller JMM, Deinhardt K, Rosewell I et al (2007) Targeted deletion of p97 (VCP/CDC48) in mouse results in early embryonic lethality. Biochem Biophys Res Commun 354:459–465. https://doi.org/10.1016/j.bbrc.2006.12.206
Ludtmann MH, Arber C, Bartolome F et al (2017) Mutations in valosin-containing protein (VCP) decrease ADP/ATP translocation across the mitochondrial membrane and impair energy metabolism in human neurons. J Biol Chem. https://doi.org/10.1074/jbc.M116.762898
Meyer HH, Wang Y, Warren G (2002) Direct binding of ubiquitin conjugates by the mammalian p97 adaptor complexes, p47 and Ufd1-Npl4. EMBO J 21:5645–5652
Buchberger A, Schindelin H, Hänzelmann P (2015) Control of p97 function by cofactor binding. FEBS Lett 589:2578–2589. https://doi.org/10.1016/j.febslet.2015.08.028
Wang T, Xu W, Qin M et al (2016) Pathogenic mutations in the valosin-containing protein/p97(VCP) N-domain inhibit the SUMOylation of VCP and lead to impaired stress response. J Biol Chem. https://doi.org/10.1074/jbc.M116.729343
Li X, Thompson D, Kumar B, DeMartino GN (2014) Molecular and cellular roles of PI31 (PSMF1) protein in regulation of proteasome function. J Biol Chem 289:17392–17405. https://doi.org/10.1074/jbc.M114.561183
Ju J-S, Fuentealba RA, Miller SE et al (2009) Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease. J Cell Biol 187:875–888. https://doi.org/10.1083/jcb.200908115
Tresse E, Salomons FA, Vesa J et al (2010) VCP/p97 is essential for maturation of ubiquitin-containing autophagosomes and this function is impaired by mutations that cause IBMPFD. Autophagy 6:217–227
Papadopoulos C, Kirchner P, Bug M et al (2017) VCP/p97 cooperates with YOD1, UBXD1 and PLAA to drive clearance of ruptured lysosomes by autophagy. EMBO J 36:135–150. https://doi.org/10.15252/embj.201695148
Ko HS, Uehara T, Tsuruma K, Nomura Y (2004) Ubiquilin interacts with ubiquitylated proteins and proteasome through its ubiquitin-associated and ubiquitin-like domains. FEBS Lett 566:110–114. https://doi.org/10.1016/j.febslet.2004.04.031
Hjerpe R, Bett JS, Keuss MJ et al (2016) UBQLN2 mediates autophagy-independent protein aggregate clearance by the proteasome. Cell 166:935–949. https://doi.org/10.1016/j.cell.2016.07.001
Xia Y, Yan LH, Huang B et al (2014) Pathogenic mutation of UBQLN2 impairs its interaction with UBXD8 and disrupts endoplasmic reticulum-associated protein degradation. J Neurochem 129:99–106. https://doi.org/10.1111/jnc.12606
N’Diaye E-N, Kajihara KK, Hsieh I et al (2009) PLIC proteins or ubiquilins regulate autophagy-dependent cell survival during nutrient starvation. EMBO Rep 10:173–179. https://doi.org/10.1038/embor.2008.238
Rothenberg C, Srinivasan D, Mah L et al (2010) Ubiquilin functions in autophagy and is degraded by chaperone-mediated autophagy. Hum Mol Genet 19:3219–3232. https://doi.org/10.1093/hmg/ddq231
Chang L, Monteiro MJ (2015) Defective proteasome delivery of polyubiquitinated proteins by ubiquilin-2 proteins containing ALS mutations. PLoS One 10:e0130162. https://doi.org/10.1371/journal.pone.0130162
Huang B, Wu Q, Zhou H et al (2016) Increased Ubqln2 expression causes neuron death in transgenic rats. J Neurochem 139:285–293. https://doi.org/10.1111/jnc.13748
Le NTT, Chang L, Kovlyagina I et al (2016) Motor neuron disease, TDP-43 pathology, and memory deficits in mice expressing ALS-FTD-linked UBQLN2 mutations. Proc Natl Acad Sci U S A 113:E7580–E7589. https://doi.org/10.1073/pnas.1608432113
Teyssou E, Chartier L, Amador M-D-M et al (2017) Novel UBQLN2 mutations linked to amyotrophic lateral sclerosis and atypical hereditary spastic paraplegia phenotype through defective HSP70-mediated proteolysis. Neurobiol Aging. https://doi.org/10.1016/j.neurobiolaging.2017.06.018
Kanekura K, Nishimoto I, Aiso S, Matsuoka M (2006) Characterization of amyotrophic lateral sclerosis-linked P56S mutation of vesicle-associated membrane protein-associated protein B (VAPB/ALS8). J Biol Chem 281:30223–30233. https://doi.org/10.1074/jbc.M605049200
Teuling E, Ahmed S, Haasdijk E et al (2007) Motor neuron disease-associated mutant vesicle-associated membrane protein-associated protein (VAP) B recruits wild-type VAPs into endoplasmic reticulum-derived tubular aggregates. J Neurosci 27:9801–9815. https://doi.org/10.1523/JNEUROSCI.2661-07.2007
Aliaga L, Lai C, Yu J et al (2013) Amyotrophic lateral sclerosis-related VAPB P56S mutation differentially affects the function and survival of corticospinal and spinal motor neurons. Hum Mol Genet 22:4293–4305. https://doi.org/10.1093/hmg/ddt279
Langou K, Moumen A, Pellegrino C et al (2010) AAV-mediated expression of wild-type and ALS-linked mutant VAPB selectively triggers death of motoneurons through a Ca2+-dependent ER-associated pathway. J Neurochem 114:795–809. https://doi.org/10.1111/j.1471-4159.2010.06806.x
Chen H-J, Anagnostou G, Chai A et al (2010) Characterization of the properties of a novel mutation in VAPB in familial amyotrophic lateral sclerosis. J Biol Chem 285:40266–40281. https://doi.org/10.1074/jbc.M110.161398
Genevini P, Papiani G, Ruggiano A et al (2014) Amyotrophic lateral sclerosis-linked mutant VAPB inclusions do not interfere with protein degradation pathways or intracellular transport in a cultured cell model. PLoS One 9:e113416. https://doi.org/10.1371/journal.pone.0113416
Navone F, Genevini P, Borgese N (2015) Autophagy and neurodegeneration: insights from a cultured cell model of ALS. Cell 4:354–386. https://doi.org/10.3390/cells4030354
Le Ber I, De Septenville A, Millecamps S et al (2015) TBK1 mutation frequencies in French frontotemporal dementia and amyotrophic lateral sclerosis cohorts. Neurobiol Aging 36:3116.e5–3116.e8. https://doi.org/10.1016/j.neurobiolaging.2015.08.009
Cirulli ET, Lasseigne BN, Petrovski S et al (2015) Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science 347:1436–1441. https://doi.org/10.1126/science.aaa3650
Corcia P, Beltran S, Vourc’h P et al (2015) TBK1 gene stresses the major role of autophagy in ALS. Rev Neurol (Paris) 171:747–749. https://doi.org/10.1016/j.neurol.2015.10.004
Ahmad L, Zhang S-Y, Casanova J-L, Sancho-Shimizu V (2016) Human TBK1: a gatekeeper of Neuroinflammation. Trends Mol Med 22:511–527. https://doi.org/10.1016/j.molmed.2016.04.006
Weidberg H, Elazar Z (2011) TBK1 mediates crosstalk between the innate immune response and autophagy. Sci Signal 4:pe39. https://doi.org/10.1126/scisignal.2002355
Matsumoto G, Shimogori T, Hattori N, Nukina N (2015) TBK1 controls autophagosomal engulfment of polyubiquitinated mitochondria through p62/SQSTM1 phosphorylation. Hum Mol Genet 24:4429–4442. https://doi.org/10.1093/hmg/ddv179
Stork B, Alers S, S. A, Wesselborg S (2012) Regulation of autophagy by protein phosphorylation. Protein Phosphorylation Hum Health
Gijselinck I, Van Mossevelde S, van der Zee J et al (2015) Loss of TBK1 is a frequent cause of frontotemporal dementia in a Belgian cohort. Neurology 85:2116–2125. https://doi.org/10.1212/WNL.0000000000002220
Richter B, Sliter DA, Herhaus L et al (2016) Phosphorylation of OPTN by TBK1 enhances its binding to Ub chains and promotes selective autophagy of damaged mitochondria. Proc Natl Acad Sci U S A 113:4039–4044. https://doi.org/10.1073/pnas.1523926113
Moore AS, Holzbaur ELF (2016) Dynamic recruitment and activation of ALS-associated TBK1 with its target optineurin are required for efficient mitophagy. Proc Natl Acad Sci U S A 113:E3349–E3358. https://doi.org/10.1073/pnas.1523810113
Chau T-L, Gioia R, Gatot J-S et al (2008) Are the IKKs and IKK-related kinases TBK1 and IKK-epsilon similarly activated? Trends Biochem Sci 33:171–180. https://doi.org/10.1016/j.tibs.2008.01.002
Chow CY, Landers JE, Bergren SK et al (2009) Deleterious variants of FIG4, a phosphoinositide phosphatase, in patients with ALS. Am J Hum Genet 84:85–88. https://doi.org/10.1016/j.ajhg.2008.12.010
Verdiani S, Origone P, Geroldi A et al (2013) The FIG4 gene does not play a major role in causing ALS in Italian patients. Amyotroph Lateral Scler Front Degener 14:228–229. https://doi.org/10.3109/21678421.2012.760605
Osmanovic A, Rangnau I, Kosfeld A et al (2017) FIG4 variants in central European patients with amyotrophic lateral sclerosis: a whole-exome and targeted sequencing study. Eur J Hum Genet EJHG 25:324–331. https://doi.org/10.1038/ejhg.2016.186
Alonso G, Phan V, Guillemain I et al (2000) Immunocytochemical localization of the sigma(1) receptor in the adult rat central nervous system. Neuroscience 97:155–170
Schröder M, Kaufman RJ (2005) The mammalian unfolded protein response. Annu Rev Biochem 74:739–789. https://doi.org/10.1146/annurev.biochem.73.011303.074134
Alemu EA, Lamark T, Torgersen KM et al (2012) ATG8 family proteins act as scaffolds for assembly of the ULK complex: sequence requirements for LC3-interacting region (LIR) motifs. J Biol Chem 287:39275–39290. https://doi.org/10.1074/jbc.M112.378109
Paschen W, Mengesdorf T (2005) Endoplasmic reticulum stress response and neurodegeneration. Cell Calcium 38:409–415. https://doi.org/10.1016/j.ceca.2005.06.019
Al-Saif A, Al-Mohanna F, Bohlega S (2011) A mutation in sigma-1 receptor causes juvenile amyotrophic lateral sclerosis. Ann Neurol 70:913–919. https://doi.org/10.1002/ana.22534
Prause J, Goswami A, Katona I et al (2013) Altered localization, abnormal modification and loss of function of sigma receptor-1 in amyotrophic lateral sclerosis. Hum Mol Genet 22:1581–1600. https://doi.org/10.1093/hmg/ddt008
Dreser A, Vollrath JT, Sechi A et al (2017) The ALS-linked E102Q mutation in sigma receptor-1 leads to ER stress-mediated defects in protein homeostasis and dysregulation of RNA-binding proteins. Cell Death Differ. https://doi.org/10.1038/cdd.2017.88
Williams KL, Topp S, Yang S et al (2016) CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia. Nat Commun. https://doi.org/10.1038/ncomms11253
Bai C, Richman R, Elledge SJ (1994) Human cyclin F. EMBO J 13:6087–6098
D’Angiolella V, Esencay M, Pagano M (2013) A cyclin without cyclin-dependent kinases: cyclin F controls genome stability through ubiquitin-mediated proteolysis. Trends Cell Biol 23:135–140. https://doi.org/10.1016/j.tcb.2012.10.011
Galligan JJ, Petersen DR (2012) The human protein disulfide isomerase gene family. Hum Genomics 6:6. https://doi.org/10.1186/1479-7364-6-6
Gonzalez-Perez P, Woehlbier U, Chian R-J et al (2015) Identification of rare protein disulfide isomerase gene variants in amyotrophic lateral sclerosis patients. Gene 566:158–165. https://doi.org/10.1016/j.gene.2015.04.035
Woehlbier U, Colombo A, Saaranen MJ et al (2016) ALS-linked protein disulfide isomerase variants cause motor dysfunction. EMBO J 35:845–865. https://doi.org/10.15252/embj.201592224
Ciechanover A, Kwon YT (2015) Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies. Exp Mol Med 47:e147. https://doi.org/10.1038/emm.2014.117
Crippa V, Sau D, Rusmini P et al (2010) The small heat shock protein B8 (HspB8) promotes autophagic removal of misfolded proteins involved in amyotrophic lateral sclerosis (ALS). Hum Mol Genet 19:3440–3456. https://doi.org/10.1093/hmg/ddq257
Wang I-F, Guo B-S, Liu Y-C et al (2012) Autophagy activators rescue and alleviate pathogenesis of a mouse model with proteinopathies of the TAR DNA-binding protein 43. Proc Natl Acad Sci U S A 109:15024–15029. https://doi.org/10.1073/pnas.1206362109
Wang X, Ma M, Teng J et al (2015) Valproate attenuates 25-kDa C-terminal fragment of TDP-43-induced neuronal toxicity via suppressing endoplasmic reticulum stress and activating autophagy. Int J Biol Sci 11:752–761. https://doi.org/10.7150/ijbs.11880
Feng H-L, Leng Y, Ma C-H et al (2008) Combined lithium and valproate treatment delays disease onset, reduces neurological deficits and prolongs survival in an amyotrophic lateral sclerosis mouse model. Neuroscience 155:567–572. https://doi.org/10.1016/j.neuroscience.2008.06.040
Bose S, Cho J (2017) Targeting chaperones, heat shock factor-1, and unfolded protein response: promising therapeutic approaches for neurodegenerative disorders. Ageing Res Rev 35:155–175. https://doi.org/10.1016/j.arr.2016.09.004
Kieran D, Kalmar B, Dick JRT et al (2004) Treatment with arimoclomol, a coinducer of heat shock proteins, delays disease progression in ALS mice. Nat Med 10:402–405. https://doi.org/10.1038/nm1021
Kalmar B, Lu C-H, Greensmith L (2014) The role of heat shock proteins in amyotrophic lateral sclerosis: the therapeutic potential of arimoclomol. Pharmacol Ther 141:40–54. https://doi.org/10.1016/j.pharmthera.2013.08.003
Yu YJ, Watts RJ (2013) Developing therapeutic antibodies for neurodegenerative disease. Neurother J Am Soc Exp Neurother 10:459–472. https://doi.org/10.1007/s13311-013-0187-4
Valera E, Masliah E (2013) Immunotherapy for neurodegenerative diseases: focus on α-synucleinopathies. Pharmacol Ther 138:311–322. https://doi.org/10.1016/j.pharmthera.2013.01.013
Gros-Louis F, Soucy G, Larivière R, Julien J-P (2010) Intracerebroventricular infusion of monoclonal antibody or its derived Fab fragment against misfolded forms of SOD1 mutant delays mortality in a mouse model of ALS. J Neurochem 113:1188–1199. https://doi.org/10.1111/j.1471-4159.2010.06683.x
Benatar M (2007) Lost in translation: treatment trials in the SOD1 mouse and in human ALS. Neurobiol Dis 26:1–13. https://doi.org/10.1016/j.nbd.2006.12.015
Renton AE, Chiò A, Traynor BJ (2014) State of play in amyotrophic lateral sclerosis genetics. Nat Neurosci 17:17–23. https://doi.org/10.1038/nn.3584
Veyrat-Durebex C, Corcia P, Dangoumau A et al (2014) Advances in cellular models to explore the pathophysiology of amyotrophic lateral sclerosis. Mol Neurobiol 49:966–983. https://doi.org/10.1007/s12035-013-8573-9
Holmes WM, Klaips CL, Serio TR (2014) Defining the limits: protein aggregation and toxicity in vivo. Crit Rev Biochem Mol Biol 49:294–303. https://doi.org/10.3109/10409238.2014.914151
Acknowledgments
This work is supported by the Region Centre Val-de-Loire, the Association ARSLA, and the MAbImprove Laboratoire d’excellence (Labex).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Maurel, C., Dangoumau, A., Marouillat, S. et al. Causative Genes in Amyotrophic Lateral Sclerosis and Protein Degradation Pathways: a Link to Neurodegeneration. Mol Neurobiol 55, 6480–6499 (2018). https://doi.org/10.1007/s12035-017-0856-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12035-017-0856-0